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IgA nephropathy:  
markers of progression  
and clues to pathogenesis
A Rifai1 and LD Dworkin2
The unpredictable progression of IgA nephropathy hinders its treatment. 
The correlation of renal dysfunction with the immunophenotype 
of leukocytic infiltrates revealed interstitial CD20+ cells and tubular 
NKG7+(GMP-17+)/CD8+ intraepithelial cells as predictive markers of 
progression in early-phase IgA nephropathy. This suggests that adaptive 
and innate immune responses mediate progression.
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A renal biopsy is required for the detec-
tion of glomerular IgA immune deposits, 
the diagnostic hallmark of IgA nephropa-
thy (IgAN). The biopsy also provides crit-
ical information about the severity of the 
histopathologic changes utilized in the 
prognosis and selection of patients for 
treatment.1 In reviewing the IgAN treat-
ment dilemma, Appel and Waldman2 
attributed the absence of a single clear 
treatment approach applicable to all IgAN 
patients to two major reasons. First, the 
pathogenesis of IgAN remains unknown. 
There is no direct relationship between 
the glomerular IgA immune deposits’ 
intensity and the extent of glomerular 
injury. This hinders the development of 
a speciﬁc therapy targeting the primary 
cause of the disease. Second, the course 
of IgAN presentation and progression is 
highly variable.
In regard to progression, an inordi-
nate number of abnormalities have been 
described in association with IgAN as 
predictive markers. In an insightful review 
and critical analysis of 30 published stud-
ies on the role of clinical and histologic 
prognostic factors in IgAN, D’Amico3 
highlighted elevated serum creatinine 
level, severe proteinuria at presenta-
tion, and a high score of glomerular and 
tubulointerstitial lesions as strong pre-
dictors. However, he cautioned that these 
prognostic markers may fail to correctly 
predict outcome in the single patient, 
probably because of the heterogeneity 
of the disease. He concluded that IgAN 
is a spectrum of diseases sharing a com-
mon pathogenetic marker, the mesangial 
IgA immune deposits, with unknown 
mechanisms propagating damage in a 
discontinuous pattern. This conclusion 
is concordant with earlier and compre-
hensive experimental observations that 
emphasized the variable characteristics of 
the immune complexes, in particular the 
nature of the antigens and the molecular 
form of IgA, as the major determinants 
of glomerular injury.4 Accordingly, the 
multivariable pathophysiologic processes 
that mediate initiation and progression of 
IgAN pose a challenge to predicting who 
is likely to develop renal failure to warrant 
an early and intensive treatment to slow 
down the rate of progression. The clinical 
ﬁndings of van Es et al.5 (this issue) now 
meet this challenge.
To enhance the precision of the mor-
phologic prognosis, several studies of 
IgAN used the technique of immunophe-
notyping to characterize and semiquantify 
the cellular inﬁltrate in the renal tissue. 
Because of restricted biopsy policy, most of 
these studies were biased toward selecting 
patients with impaired renal function and 
a high risk of progression. The real need is 
for prognostic markers that can be detected 
in renal biopsies of patients in the early 
stage of IgAN with a normal glomerular 
ﬁltration rate (GFR) to identify those who 
will progress to renal failure. Recognizing 
this need, van Es et al.5 conducted retro-
spective and comprehensive analysis that 
related the clinical course, over an 18-year 
period, to the morphologic and immuno-
histologic changes in renal biopsies from 
50 IgAN patients grouped into either 
normal GFR (n = 31) or decreased GFR 
(n = 19) at biopsy. They used a panel of 
monoclonal antibodies against a variety 
of leukocytic markers — CD3, CD4, CD8, 
CD20, CD45, CD68, HLA-DR, and GMP-
17 (see note regarding terminology below) 
— to immunophenotype and localize the 
renal inﬁltrates. In comparing the immu-
nophenotype scores of 13 progressors and 
18 non-progressors in the normal GFR 
group, they discovered that all the leuko-
cytic markers, with the exception of CD68 
(macrophages), were signiﬁcantly higher in 
the progressors. This ﬁnding is consistent 
with previous reports. In the progressors 
who presented with normal GFR, statistical 
analysis of the morphologic changes and 
immunophenotypic parameters revealed 
NKG7+(GMP-17+)/CD8+ intraepithelial 
lymphocytes (IELs) in the tubules as the 
most sensitive marker with the highest 
likelihood ratio. Interstitial CD20+ (B cell) 
was equally sensitive with the second high-
est likelihood ratio. Univariate analysis of 
the clinical, histopathologic, and immuno-
histochemical parameters showed tubular 
atrophy, interstitial inﬁltrate, interstitial 
NKG7+(GMP-17+)/CD8+ T cells, intersti-
tial CD20+ cells, and NKG7+(GMP-17+)/
CD8+ IELs as signiﬁcant predictors. Fur-
ther evaluation by multivariate analysis 
confirmed only the last two markers as 
predictors of progression in IgAN patients 
with normal GFR.
First a brief note to clarify the relation-
ship between the term GMP-17 and the 
gene NKG7. Medley et al.6 reported on the 
monoclonal antibody 2G9, used in this 
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study, and showed that it binds to a small 
protein in the cytoplasmic granules of nat-
ural killer cell lines, designated GMP-17 
(for granule membrane protein of 17 kilo-
daltons). Searches of National Center for 
Biotechnology Information databases and 
the European Ensembl database reveal that 
there is no gene with the GMP-17 desig-
nation. Sequence analysis and homology 
search of the GMP-17 protein6 revealed 
that it is a product of an already known 
gene, NKG7 (natural killer cell group 7 
sequence). Thus, we use the gene name 
NKG7 in lieu of the term GMP-17. NKG7, a 
four-pass transmembrane protein, is a cal-
cium ion channel that is highly expressed 
in natural killer cells and activated T-cell 
receptor-αβ-expressing CD8+ T cells 
(http://www.genecards.org/).
Despite the limited number of patients 
in the study by van Es et al.,5 highly sig-
niﬁcant predictive values were obtained for 
the interstitial CD20+ cells and the tubu-
lar NKG7+/CD8+ IELs. As the authors 
acknowledge, an independent prospec-
tive study of a larger patient population 
is needed to confirm the clinical utility 
of these two markers. An alternative and 
expedient approach is to analyze the data 
by using the novel statistical method of 
least-angle regression, recently described 
by Lemley et al.,7 for investigating a large 
set of quantitative predictors of progres-
sion in a small number of IgAN patients. 
Concurrence of least-angle regression with 
the multivariate analysis will also reinforce 
the predictive value of these two markers. 
Regardless of the outcome, the results of van 
Es et al.5 provide important insights into 
the immunologic mechanisms that may 
help in the development of new treatment 
focused on postglomerular injury.
Identiﬁcation of interstitial CD20+ cells 
as a predictive marker of progression by 
van Es et al.5 is concordant with the early 
ﬁndings by Sabadani et al.8 Recently, Seg-
erer and Schlöndorﬀ 9 summarized their 
similar ﬁndings of interstitial CD20+ cells 
in IgAN, membranous nephropathy, and 
renal allografts. They also reviewed how 
B cells contribute to interstitial inﬂam-
mation, whereby the chemokine receptor 
CXCR5 on B cells and its cognate ligand 
CXCL13/BLC in renal tissue play a major 
role in directing B cells’ participation in 
renal interstitial inflammation and the 
formation of tertiary lymphoid organs. 
Renal tertiary lymphoid organs have Duﬀy 
antigen receptor for chemokines–positive 
vessels that serve as a conduit for leuko-
cytic emigration from the circulation into 
the tubulointerstitium. The relationship 
among B cells, CD8+ cells, tertiary lym-
phoid organs, and development of tubu-
litis needs to be investigated.
Despite a vast amount of histopathologic 
evidence demonstrating that the presence 
of tubular atrophy is an indicator of poor 
outcome of renal function, the primary 
role of tubular injury has not been explored 
adequately in IgAN. The novel ﬁndings of 
van Es et al.5 showing that NKG7+/CD8+ 
IEL localization in the tubules is associated 
with progression also shed new light on 
Figure 1 | Postulated mechanisms involved in CD8+ T-cell–mediated tubular injury. (a) In the 
adaptive model, the NKG7+/CD8+ intraepithelial lymphocytes (IELs) may originate as conventional 
antigen-specific effector memory CD8+ cells that are recruited to the tubular compartment in 
response to local production of chemokines (CCL2, CCL3, CCL5) that are sequestered in the tubular 
basement membrane. Transforming growth factor-β (TGF–β) in the intratubular microenvironment 
will induce the CD8+ cells to express the integrin αEβ7 (CD103), which binds to E-cadherin on the 
basolateral surface of the polarized tubular epithelial cells. Exposure of the NKG7+/CD8+ IELs to 
interleukin-15 (IL-15), also produced by the tubular cells, will sustain their growth. The synergy of 
TGF–β and IL-15 and their antiapoptotic action downregulate perforin expression while sustaining 
the persistence of NKG7+/CD8+ IELs. Binding of T-cell receptor (TCR)-αβ to the peptide antigen 
presented by major histocompatibility complex class I (MHC-I) activates the cell and induces FasL 
expression. Interaction of FasL with its cognate receptor Fas on tubular cells leads to their apoptosis. 
(b) In the TCR-independent innate immune response model, NKG7+/CD8+ IELs express the 
promiscuous NKG2D (natural killer group 2, member D) receptor. Cellular stress induces expression 
of MHC-I-related proteins (MICA and MICB) that serve as NKG2D ligands. Activating signals delivered 
through NKG2D to the adaptor protein (DAP10) initiate the phosphatidylinositol-3′-kinase signal 
transduction cascade. IL-15 and TGF–β also might modulate the NKG2D activity by stimulating the 
expansion of IELs and enhancing the expression of MICA/B on stressed cells.
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immune mechanisms mediating tubular 
injury. Tubulitis, invasion of the tubular 
epithelium by inﬁltrating T cells and mac-
rophages, is a diagnostic feature of acute 
cellular rejection of renal allografts.10 This 
raises the question of whether tubulitis in 
IgAN progressors recapitulates the same 
process. The answer is negative. As van 
Es et al.5 document, there is a paucity of 
macrophages and CD4+ T lymphocytes 
inﬁltrating tubules of early IgAN progres-
sors. In contrast, the tubulitis pattern of 
renal allografts is full of macrophages and 
mostly of CD4+ and CD8+ T cells that 
contain cytotoxic granules (perforin and 
granzyme A/B) or the cytotoxic eﬀector 
ligand FasL.10 The absence of both per-
forin and granzyme A/B from NKG7+/
CD8+ IELs in IgAN progressors is another 
important feature that contrasts with 
the allograft-inﬁltrating CD8+ cytotoxic 
T lymphocytes. Consequently, what are the 
immune mechanisms engaged by NKG7+/
CD8+ IELs that inﬂict tubular injury? The 
answer is unknown. However, on the basis 
of the localization of NKG7+/CD8+ IELs 
in intact and atrophic tubules, we postu-
late two complementary mechanisms of 
adaptive and innate CD8+ T cell-mediated 
tubular injury. The ﬁrst mechanism (sche-
matized in Figure 1a) proposes that the 
T-cell receptors on NKG7+/CD8+ cells 
mediate the cytotoxic response to either 
cross-presented exogenous antigen or 
an endogenous antigen produced by the 
tubules. Also, the antiapoptotic action 
of transforming growth factor-β and 
interleukin-15, along with the expression of 
CD103 that binds to E-cadherin on tubular 
cells, allows NKG7+/CD8+ IELs to persist 
and cause disruption of the tubular struc-
ture and function. The second mechanism 
(schematized in Figure 1b) proposes the 
innate immune response of the NKG7+/
CD8+ IELs as a mediator of tubulitis. The 
primary function of sentinel CD8+ IELs is 
to sustain epithelial integrity by eliminat-
ing stressed cells. The CD8+ IELs express 
a variety of NK cell–lineage receptors, 
among which is the NKG2D activating 
receptor. Under stress conditions, epithelial 
cells express major histocompatibility com-
plex class I chain-related proteins (MICA 
or MICB) that serve as ligands of NKG2D, 
hence targeting the cells for cytolysis and 
elimination. These are minimal models 
inspired by the study of van Es et al.5 
Their clinical relevance needs to be ascer-
tained in future investigations.
The seminal report by van Es et al.5 
will enhance the clinical utility of renal 
biopsy early in IgAN to predict progres-
sion. Importantly, the novel discovery 
of NKG7+/CD8+ IELs’ association with 
tubulitis implicates this specialized T-cell 
subset as a mediator of nephron injury. 
Finally, we envisage that targeted inhibi-
tion of NKG7+/CD8+ cells could be of 
therapeutic value, especially as an adjunct 
supplement to other therapeutic strategies 
aimed at IgAN.
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The challenge of discovering 
patient-level cardiovascular risk 
factors in chronic kidney disease
R Agarwal1
The goal of developing a CKD-specific cardiovascular risk score remains 
elusive and difficult. One approach to develop such a score is to 
evaluate conventional cardiovascular risk factors in an outcomes model. 
Nontraditional risk factors such as albuminuria can then be tested to 
evaluate the predictive value of these markers over and above traditional 
risk factors for patient-level decision making.
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In 1948, the United States Public Health 
Service initiated a community-based 
epidemiological study in Framingham, 
Massachusetts, to uncover environmental 
and personal factors associated with the 
subsequent appearance and progres-
sion of cardiovascular diseases.1 At ﬁrst 
examination of this cohort, 898 men and 
1,107 women aged 45–62 who appeared 
clinically well underwent a thorough 
history, physical examination, and labo-
ratory evaluation.2 In 1957, a report of 
a 4-year follow-up revealed 52 cases of 
coronary heart disease in men and 32 
cases in women. Blood pressure, relative 
body weight, and the serum cholesterol 
